Immunocore Ltd of Oxford, UK has secured another partnership with a major pharmaceutical company relating to the exploitation of its recombinant T cell receptor technology platform – this time with Eli Lilly and Company. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
